Abel, Kristina, Van Rompay, Koen KA, Eastlick, Juliet, Moore, Joseph, Lemieux, Mathieu, Schmidt, Kimberly, ...
No abstract available.
Van Rompay, Koen KA, Johnson, Jeffrey A, Blackwood, Emily J, Singh, Raman P, Lipscomb, Jonathan, Matthews, Timothy B, ...
Abstract Background We reported previously on the emergence and clinical implications of simian immunodeficiency virus (SIVmac251) mutants with a K65R mutation in reverse transcriptase (RT), and the...
Non-neutralizing antibodies and vaccine-induced protection (2006)
Demberg, Thorsten, Florese, Ruth H, Gomez-Roman, V Raul, Larsen, Kay, Van Rompay, Koen KA, Marthas, Marta L, ...
No abstract available.
Van Rompay, Koen KA, Blackwood, Emily J, Landucci, Gary, Forthal, Don, Marthas, Marta L
Abstract Infection of macaques with the avirulent molecular clone SIVmac1A11 results in transient low viremia and no disease. To investigate if this low viremia is solely due to intrinsic poor...
Greenier, Jennifer L, Van Rompay, Koen KA, Montefiori, David, Earl, Patricia, Moss, Bernard, Marthas, Marta L
Abstract Background Oral infection of infant macaques with simian immunodeficiency virus (SIV) is a useful animal model to test interventions to reduce postnatal HIV transmission via breast-feeding....
Van Rompay, Koen K. A., Cherrington, Julie M., Marthas, Marta L., Lamy, Patrick D., Dailey, Peter J., Canfield, Don R., ...
Simian immunodeficiency virus (SIV) infection of newborn rhesus macaques is a useful animal model of human immunodeficiency virus infection for the study of the emergence and clinical implications of...
Van Rompay, Koen K. A., Dailey, Peter J., Tarara, Ross P., Canfield, Don R., Aguirre, Nancy L., Cherrington, Julie M., ...
Simian immunodeficiency virus (SIV) infection of newborn macaques is a useful animal model of human pediatric AIDS to study disease pathogenesis and to develop intervention strategies aimed at...
Van Rompay, Koen K. A., Miller, Michael D., Marthas, Marta L., Margot, Nicolas A., Dailey, Peter J., Canfield, Don R., ...
Simian immunodeficiency virus (SIV) infection of newborn macaques is a useful animal model of human pediatric AIDS to study pathogenesis and to develop intervention strategies aimed at preventing...
Greenier, Jennifer L., Miller, Christopher J., Lu, Ding, Dailey, Peter J., Lü, Fabien X., Kunstman, Kevin J., ...
A better understanding of the host and viral factors associated with human immunodeficiency virus (HIV) transmission is essential to developing effective strategies to curb the global HIV epidemic....
Rev-Independent Simian Immunodeficiency Virus Strains Are Nonpathogenic in Neonatal Macaques
Von Gegerfelt, Agneta S., Liska, Vladimir, Li, Pei-Lin, McClure, Harold M., Horie, Kyoji, Nappi, Filomena, ...
The viral protein Rev is essential for the export of the subset of unspliced and partially spliced lentiviral mRNAs and the production of structural proteins. Rev and its RNA binding site RRE can be...
Van Rompay, Koen K. A., Greenier, Jennifer L., Cole, Kelly Stefano, Earl, Patricia, Moss, Bernard, Steckbeck, Jonathan D., ...
There is an urgent need for active immunization strategies that, if administered shortly after birth, could protect infants in developing countries from acquiring human immunodeficiency virus (HIV)...
Makori, Norbert, Tarantal, Alice F., Lü, Fabien X., Rourke, Tracy, Marthas, Marta L., McChesney, Michael B., ...
Little is known regarding the timing of immune ontogeny and effector function in fetal humans and nonhuman primates. We studied the organization of lymphocyte and antigen-presenting cell populations...
Vogel, Thorsten U., Reynolds, Matthew R., Fuller, Deborah H., Vielhuber, Kathy, Shipley, Tim, Fuller, James T., ...
Given the current difficulties generating vaccine-induced neutralizing antibodies to human immunodeficiency virus (HIV), the focus of the vaccine community has shifted toward creating...
CD8+-Cell-Mediated Suppression of Virulent Simian Immunodeficiency Virus during Tenofovir Treatment
Van Rompay, Koen K. A., Singh, Raman P., Pahar, Bapi, Sodora, Donald L., Wingfield, Casey, Lawson, Jonathan R., ...
The ability of tenofovir to suppress viremia in simian immunodeficiency virus (SIV)-infected macaques for years despite the presence of virulent viral mutants with reduced in vitro susceptibility is...
Van Rompay, Koen K. A., Brignolo, Laurie L., Meyer, Dennis J., Jerome, Christopher, Tarara, Ross, Spinner, Abigail, ...
The reverse transcriptase inhibitor 9-[2-(phosphonomethoxy)propyl]adenine (PMPA; tenofovir) was previously found to offer strong prophylactic and therapeutic benefits in an infant macaque model of...
Van Rompay, Koen K. A., Brignolo, Laurie L., Meyer, Dennis J., Jerome, Christopher, Tarara, Ross, Spinner, Abigail, ...
Greenier, Jennifer L, Van Rompay, Koen KA, Montefiori, David, Earl, Patricia, Moss, Bernard, Marthas, Marta L
Van Rompay, Koen KA, Blackwood, Emily J, Landucci, Gary, Forthal, Don, Marthas, Marta L
Infection of macaques with the avirulent molecular clone SIVmac1A11 results in transient low viremia and no disease. To investigate if this low viremia is solely due to intrinsic poor replication...
Abel, Kristina, Pahar, Bapi, Van Rompay, Koen K. A., Fritts, Linda, Sin, Clarissa, Schmidt, Kimberli, ...
A vaccine to protect human immunodeficiency virus (HIV)-exposed infants is an important goal in the global fight against the HIV pandemic. Two major challenges in pediatric HIV vaccine design are the...
Van Rompay, Koen K. A., Singh, Raman P., Heneine, Walid, Johnson, Jeffrey A., Montefiori, David C., Bischofberger, Norbert, ...
We demonstrated previously that prolonged tenofovir treatment of infant macaques, starting early during infection with virulent simian immunodeficiency virus (SIVmac251), can lead to persistently low...
Van Rompay, Koen K. A., Cherrington, Julie M., Marthas, Marta L., Lamy, Patrick D., Dailey, Peter J., Canfield, Don R., ...
Simian immunodeficiency virus (SIV) infection of newborn rhesus macaques is a useful animal model of human immunodeficiency virus infection for the study of the emergence and clinical implications of...
Van Rompay, Koen K. A., Dailey, Peter J., Tarara, Ross P., Canfield, Don R., Aguirre, Nancy L., Cherrington, Julie M., ...
Simian immunodeficiency virus (SIV) infection of newborn macaques is a useful animal model of human pediatric AIDS to study disease pathogenesis and to develop intervention strategies aimed at...
Van Rompay, Koen K. A., Miller, Michael D., Marthas, Marta L., Margot, Nicolas A., Dailey, Peter J., Canfield, Don R., ...
Simian immunodeficiency virus (SIV) infection of newborn macaques is a useful animal model of human pediatric AIDS to study pathogenesis and to develop intervention strategies aimed at preventing...
Greenier, Jennifer L., Miller, Christopher J., Lu, Ding, Dailey, Peter J., Lü, Fabien X., Kunstman, Kevin J., ...
A better understanding of the host and viral factors associated with human immunodeficiency virus (HIV) transmission is essential to developing effective strategies to curb the global HIV epidemic....
Rev-Independent Simian Immunodeficiency Virus Strains Are Nonpathogenic in Neonatal Macaques
Von Gegerfelt, Agneta S., Liska, Vladimir, Li, Pei-Lin, McClure, Harold M., Horie, Kyoji, Nappi, Filomena, ...
The viral protein Rev is essential for the export of the subset of unspliced and partially spliced lentiviral mRNAs and the production of structural proteins. Rev and its RNA binding site RRE can be...
Van Rompay, Koen K. A., Greenier, Jennifer L., Cole, Kelly Stefano, Earl, Patricia, Moss, Bernard, Steckbeck, Jonathan D., ...
There is an urgent need for active immunization strategies that, if administered shortly after birth, could protect infants in developing countries from acquiring human immunodeficiency virus (HIV)...
Makori, Norbert, Tarantal, Alice F., Lü, Fabien X., Rourke, Tracy, Marthas, Marta L., McChesney, Michael B., ...
Little is known regarding the timing of immune ontogeny and effector function in fetal humans and nonhuman primates. We studied the organization of lymphocyte and antigen-presenting cell populations...
Vogel, Thorsten U., Reynolds, Matthew R., Fuller, Deborah H., Vielhuber, Kathy, Shipley, Tim, Fuller, James T., ...
Given the current difficulties generating vaccine-induced neutralizing antibodies to human immunodeficiency virus (HIV), the focus of the vaccine community has shifted toward creating...
CD8+-Cell-Mediated Suppression of Virulent Simian Immunodeficiency Virus during Tenofovir Treatment
Van Rompay, Koen K. A., Singh, Raman P., Pahar, Bapi, Sodora, Donald L., Wingfield, Casey, Lawson, Jonathan R., ...
The ability of tenofovir to suppress viremia in simian immunodeficiency virus (SIV)-infected macaques for years despite the presence of virulent viral mutants with reduced in vitro susceptibility is...
Van Rompay, Koen K. A., Brignolo, Laurie L., Meyer, Dennis J., Jerome, Christopher, Tarara, Ross, Spinner, Abigail, ...
The reverse transcriptase inhibitor 9-[2-(phosphonomethoxy)propyl]adenine (PMPA; tenofovir) was previously found to offer strong prophylactic and therapeutic benefits in an infant macaque model of...
Van Rompay, Koen K. A., Brignolo, Laurie L., Meyer, Dennis J., Jerome, Christopher, Tarara, Ross, Spinner, Abigail, ...
Greenier, Jennifer L, Van Rompay, Koen KA, Montefiori, David, Earl, Patricia, Moss, Bernard, Marthas, Marta L
Abel, Kristina, Pahar, Bapi, Van Rompay, Koen K. A., Fritts, Linda, Sin, Clarissa, Schmidt, Kimberli, ...
A vaccine to protect human immunodeficiency virus (HIV)-exposed infants is an important goal in the global fight against the HIV pandemic. Two major challenges in pediatric HIV vaccine design are the...
Van Rompay, Koen K. A., Singh, Raman P., Heneine, Walid, Johnson, Jeffrey A., Montefiori, David C., Bischofberger, Norbert, ...
We demonstrated previously that prolonged tenofovir treatment of infant macaques, starting early during infection with virulent simian immunodeficiency virus (SIVmac251), can lead to persistently low...
Van Rompay, Koen KA, Blackwood, Emily J, Landucci, Gary, Forthal, Don, Marthas, Marta L
Infection of macaques with the avirulent molecular clone SIVmac1A11 results in transient low viremia and no disease. To investigate if this low viremia is solely due to intrinsic poor replication...
Non-neutralizing antibodies and vaccine-induced protection
Demberg, Thorsten, Florese, Ruth H, Gomez-Roman, V Raul, Larsen, Kay, Van Rompay, Koen KA, Marthas, Marta L, ...